Published in Br J Psychiatry on January 01, 2005
Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry (2012) 1.91
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther (2009) 1.67
Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull (2006) 1.54
Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophr Bull (2008) 1.52
Deconstructing psychosis with human brain imaging. Schizophr Bull (2007) 1.35
Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments. Schizophr Res (2008) 1.32
Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res (2012) 1.32
Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull (2010) 1.23
Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review. Cogn Neuropsychiatry (2012) 1.19
At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry (2015) 1.15
Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Med (2006) 1.13
Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? World Psychiatry (2011) 1.04
Premorbid cognitive deficits in young relatives of schizophrenia patients. Front Hum Neurosci (2010) 1.01
Early and broadly defined psychosis risk mental states. Schizophr Res (2010) 1.01
Multivariate prediction of emerging psychosis in adolescents at high risk for schizophrenia. Schizophr Res (2012) 1.01
The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull (2010) 1.00
Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci (2010) 0.99
Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia. Clin Schizophr Relat Psychoses (2010) 0.98
A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome. Res Dev Disabil (2013) 0.96
Neuropsychological performance and family history in children at age 7 who develop adult schizophrenia or bipolar psychosis in the New England Family Studies. Psychol Med (2012) 0.95
Specificity of familial transmission of schizophrenia psychosis spectrum and affective psychoses in the New England family study's high-risk design. Arch Gen Psychiatry (2010) 0.94
MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms. Schizophr Res (2007) 0.93
Premorbid neurocognitive functioning in schizophrenia spectrum disorder. Schizophr Bull (2006) 0.92
Childhood attention-deficit/hyperactivity disorder and the emergence of personality disorders in adolescence: a prospective follow-up study. J Clin Psychiatry (2008) 0.91
Correlations between fMRI activation and individual psychotic symptoms in un-medicated subjects at high genetic risk of schizophrenia. BMC Psychiatry (2007) 0.89
Developing psychosis and its risk states through the lens of schizotypy. Schizophr Bull (2014) 0.88
Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.88
Grey matter and cognitive deficits in young relatives of schizophrenia patients. Neuroimage (2010) 0.88
Models of neurodevelopmental abnormalities in schizophrenia. Curr Top Behav Neurosci (2010) 0.88
Predictors of psychosis: a 50-year follow-up of the Lundby population. Eur Arch Psychiatry Clin Neurosci (2009) 0.87
An integrated psychobiological predictive model of emergent psychopathology among young relatives at risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.87
The assessment of schizotypy and its clinical relevance. Schizophr Bull (2015) 0.86
Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia? J Neural Transm (Vienna) (2007) 0.84
Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential. Br J Pharmacol (2008) 0.83
Early prodromal symptoms can predict future psychosis in familial high-risk youth. J Psychiatr Res (2011) 0.83
Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders. Psychiatry Res (2013) 0.81
Depressive Symptoms and Brain Metabolite Alterations in Subjects at Ultra-high Risk for Psychosis: A Preliminary Study. Psychiatry Investig (2009) 0.81
Psychosis prediction and clinical utility in familial high-risk studies: selective review, synthesis, and implications for early detection and intervention. Early Interv Psychiatry (2013) 0.81
The presentation of dermatoglyphic abnormalities in schizophrenia: a meta-analytic review. Schizophr Res (2012) 0.80
Evidence that transition from health to psychotic disorder can be traced to semi-ubiquitous environmental effects operating against background genetic risk. PLoS One (2013) 0.80
Neural disruption to theory of mind predicts daily social functioning in individuals at familial high-risk for schizophrenia. Soc Cogn Affect Neurosci (2014) 0.79
Predictors of a clinical high risk status among individuals with a family history of psychosis. Schizophr Res (2013) 0.78
Negative symptoms in youths with psychosis spectrum features: complementary scales in relation to neurocognitive performance and function. Schizophr Res (2015) 0.78
The "polyenviromic risk score": Aggregating environmental risk factors predicts conversion to psychosis in familial high-risk subjects. Schizophr Res (2016) 0.77
PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain. Neuroscience (2016) 0.77
Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration. Neuropsychopharmacology (2016) 0.77
Brief Report: The Association of Autistic Traits and Behavioural Patterns in Adolescents Receiving Special Educational Assistance. J Autism Dev Disord (2015) 0.77
Cognitive alexithymia is associated with the degree of risk for psychosis. PLoS One (2015) 0.76
Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis. Arch Med Sci (2015) 0.76
Genetic Variants of Interleukin-10 Gene Promoter are Associated with Schizophrenia in Saudi Patients: A Case-Control Study. N Am J Med Sci (2014) 0.76
Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine Treatment. Front Behav Neurosci (2017) 0.76
Links between Autism Spectrum Disorder Diagnostic Status and Family Quality of Life. Children (Basel) (2017) 0.75
Preceding diagnoses to young adult bipolar disorder and schizophrenia in a nationwide study. BMC Psychiatry (2013) 0.75
The early identification of psychosis: can lessons be learnt from cardiac stress testing? Psychopharmacology (Berl) (2015) 0.75
Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia. Neuropsychiatr Dis Treat (2017) 0.75
Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sample. Schizophr Res (2015) 0.75
Impact of Familial Loading on Prefrontal Activation in Major Psychiatric Disorders: A Near-Infrared Spectroscopy (NIRS) Study. Sci Rep (2017) 0.75
A qualitative phenomenological analysis of the subjective experience and understanding of the at risk mental state. Int J Qual Stud Health Well-being (2017) 0.75
School-associated problem behavior in childhood and adolescence and development of adult schizotypal symptoms: a follow-up of a clinical cohort. J Abnorm Child Psychol (2014) 0.75
Scottish independence: the view of psychiatry from Edinburgh. BJPsych Bull (2017) 0.75
Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features. Trends Cogn Sci (2017) 0.75
Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS). Schizophr Res (2017) 0.75
Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ (2012) 5.26
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Functional specialization within rostral prefrontal cortex (area 10): a meta-analysis. J Cogn Neurosci (2006) 3.67
The 'continuum of psychosis': scientifically unproven and clinically impractical. Br J Psychiatry (2010) 2.86
Contextual determinants of alcohol consumption changes and preventive alcohol policies: a 12-country European study in progress. Subst Use Misuse (2011) 2.81
Towards a neuroanatomy of autism: a systematic review and meta-analysis of structural magnetic resonance imaging studies. Eur Psychiatry (2007) 2.31
A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci (2006) 2.16
Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage (2005) 2.09
Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol (2005) 2.06
A meta-analysis of depression severity and cognitive function. J Affect Disord (2009) 1.94
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry (2011) 1.75
White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging. Bipolar Disord (2009) 1.71
Social cognition and face processing in schizophrenia. Br J Psychiatry (2004) 1.67
Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Res (2004) 1.66
A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2010) 1.63
White matter tractography in bipolar disorder and schizophrenia. Biol Psychiatry (2008) 1.58
CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord (2013) 1.56
A systematic review of diffusion tensor imaging studies in affective disorders. Biol Psychiatry (2009) 1.54
The application of nonlinear Dynamic Causal Modelling for fMRI in subjects at high genetic risk of schizophrenia. Neuroimage (2013) 1.52
Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophr Bull (2008) 1.52
Family structure, parent-child relationships, and alcohol and other drug use among teenagers in France and the United Kingdom. Alcohol Alcohol (2002) 1.50
Schizophrenia, poor physical health and physical activity: evidence-based interventions are required to reduce major health inequalities. Br J Psychiatry (2013) 1.49
Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. Neuroimage (2002) 1.48
White matter density in patients with schizophrenia, bipolar disorder and their unaffected relatives. Biol Psychiatry (2005) 1.47
Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biol Psychiatry (2006) 1.45
Transcranial stimulation in depression. Br J Psychiatry (2012) 1.42
Functional disconnectivity in subjects at high genetic risk of schizophrenia. Brain (2005) 1.41
Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology (2013) 1.40
A systematic review and meta-analysis of the fMRI investigation of autism spectrum disorders. Neurosci Biobehav Rev (2011) 1.38
Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms. Br J Psychiatry (2002) 1.38
Overactivation of fear systems to neutral faces in schizophrenia. Biol Psychiatry (2008) 1.38
Psychotic depression. BMJ (2012) 1.37
Deconstructing psychosis with human brain imaging. Schizophr Bull (2007) 1.35
Prefrontal function and activation in bipolar disorder and schizophrenia. Am J Psychiatry (2008) 1.35
Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives. Biol Psychiatry (2004) 1.33
Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry (2009) 1.31
Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association? Biol Psychiatry (2011) 1.29
Functional Magnetic Resonance Imaging (fMRI) reproducibility and variance components across visits and scanning sites with a finger tapping task. Neuroimage (2009) 1.29
A systematic review and meta-analysis of magnetic resonance imaging studies in late-life depression. Am J Geriatr Psychiatry (2013) 1.28
Multi-centre diagnostic classification of individual structural neuroimaging scans from patients with major depressive disorder. Brain (2012) 1.27
Specialty choice in UK junior doctors: is psychiatry the least popular specialty for UK and international medical graduates? BMC Med Educ (2009) 1.25
Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry (2004) 1.24
Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry (2007) 1.23
White matter integrity in individuals at high genetic risk of bipolar disorder. Biol Psychiatry (2011) 1.23
The effects of APOE on the functional architecture of the resting brain. Neuroimage (2011) 1.22
The cognitive neuropsychology of depression in the elderly. Psychol Med (2007) 1.22
Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: a voxel-based meta-analysis of functional magnetic resonance imaging studies. Eur Neuropsychopharmacol (2011) 1.21
Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia. Schizophr Res (2003) 1.21
Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure. Am J Med Genet B Neuropsychiatr Genet (2006) 1.17
Structural abnormalities of ventrolateral and orbitofrontal cortex in patients with familial bipolar disorder. Bipolar Disord (2009) 1.15
Voxel-based morphometry of comorbid schizophrenia and learning disability: analyses in normalized and native spaces using parametric and nonparametric statistical methods. Neuroimage (2004) 1.14
Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Med (2006) 1.13
Midbrain activation during Pavlovian conditioning and delusional symptoms in schizophrenia. Arch Gen Psychiatry (2010) 1.11
Prefrontal cortical functional abnormality in major depressive disorder: a stereotactic meta-analysis. J Affect Disord (2006) 1.11
Female philopatry in coastal basins and male dispersion across the North Atlantic in a highly mobile marine species, the sperm whale (Physeter macrocephalus). Mol Ecol (2009) 1.11
The effect of electroconvulsive therapy on autobiographical memory: a systematic review. J ECT (2008) 1.11
Neuropsychological impairments in people with schizophrenia or bipolar disorder and their unaffected relatives. Br J Psychiatry (2005) 1.10
Longitudinal volume reductions in people at high genetic risk of schizophrenia as they develop psychosis. Biol Psychiatry (2010) 1.08
Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry (2006) 1.08
Functional imaging as a predictor of schizophrenia. Biol Psychiatry (2006) 1.07
Pathogenesis of schizophrenia: a psychopathological perspective. Br J Psychiatry (2005) 1.06
Family structure and adolescent cigarette smoking in eleven European countries. Addiction (2003) 1.04
DISC1 in schizophrenia: genetic mouse models and human genomic imaging. Schizophr Bull (2010) 1.04
Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder. Neuropsychopharmacology (2012) 1.04
Magnetic resonance imaging in late-life depression: multimodal examination of network disruption. Arch Gen Psychiatry (2012) 1.04
Similarity-based extraction of individual networks from gray matter MRI scans. Cereb Cortex (2011) 1.03
Meta-analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome). Schizophr Res (2009) 1.03
Vascular risk factors and depression in later life: a systematic review and meta-analysis. Biol Psychiatry (2012) 1.02
Genetic variation in CNTNAP2 alters brain function during linguistic processing in healthy individuals. Am J Med Genet B Neuropsychiatr Genet (2011) 1.01
The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull (2010) 1.00
Emotional memory in schizophrenia. Neuropsychologia (2006) 1.00
The neural basis of familial risk and temperamental variation in individuals at high risk of bipolar disorder. Biol Psychiatry (2011) 1.00
Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biol Psychiatry (2006) 1.00
MRI correlates of episodic memory in Alzheimer's disease, mild cognitive impairment, and healthy aging. Psychiatry Res (2010) 1.00
Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry (2008) 1.00
Lexical and semantic fluency discrepancy scores in aMCI and early Alzheimer's disease. J Neuropsychol (2009) 0.99
Symptomatology and social inference: a theory of mind study of schizophrenia and psychotic affective disorder. Cogn Neuropsychiatry (2005) 0.99
Abnormal cortical folding in high-risk individuals: a predictor of the development of schizophrenia? Biol Psychiatry (2004) 0.99
Predictors of cognitive impairment in an early stage Parkinson's disease cohort. Mov Disord (2014) 0.98
The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task. Psychopharmacology (Berl) (2006) 0.98
Brain structure in adolescents and young adults with alcohol problems: systematic review of imaging studies. Alcohol Alcohol (2013) 0.97
RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 Inventory. Epilepsy Behav (2010) 0.97
Prospective multi-centre Voxel Based Morphometry study employing scanner specific segmentations: procedure development using CaliBrain structural MRI data. BMC Med Imaging (2009) 0.96
Low birthweight and preterm birth in young people with special educational needs: a magnetic resonance imaging analysis. BMC Med (2008) 0.96